Electronegativity and Polarity

Not all atoms pull on electrons with the same force. Electronegativity quantifies an atom's ability to attract shared electrons toward itself within a covalent bond. Formalised by Linus Pauling in 1932, it is measured on the Pauling scale, ranging from approximately 0.7 (caesium, a weakly attracting metal) to 4.0 (fluorine, the strongest electron acceptor).

Why does this matter for drugs? Because electronegativity differences create uneven charge distributions within molecules. These charge imbalances generate the electrostatic complementarity and hydrogen-bonding capacity that allow a drug to recognise and engage its biological target. Without them, molecules would be electrically uniform and unable to form the precise interactions required for pharmacological activity.

Here are the Pauling electronegativity values for all nine drug-relevant elements:

F (4.0) > O (3.4) > Cl (3.2) > N (3.0) > Br (3.0) > S (2.6) ≈ C (2.6) > H (2.2) ≈ P (2.2)

Notice the trend: electronegativity generally increases moving right and up across the periodic table. The small, lightweight elements that dominate drug chemistry (O, N, F) are among the most electronegative.